Bioequivalence Study of Atenolol 100mg Tablets Under Fasting Conditions
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2008-10-20
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 36
- Registration Number
- NCT00775580
- Locations
- 🇺🇸
aaiPharma, Inc. -AAI Clinic, Chapell Hill, North Carolina, United States
Bioequivalency Study of Fenofibrate 160mg Tablets Under Fasting Conditions
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2008-10-20
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00775827
- Locations
- 🇮🇳
Ranbaxy Research Laboratories, Gurgaon, Haryana, India
Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2008-10-20
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00775255
Bioequivalence Study of Amlodipine 10mg Tablets Under Fed Conditions
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2008-10-20
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00775151
- Locations
- 🇺🇸
SFBC Ft. Myers, Inc., Fort Myers, Florida, United States
Bioequivalence Study of Doxycycline Monohydrate 100mg Tablets Under Fasting Conditions
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2008-10-20
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT00775177
- Locations
- 🇺🇸
aaiPharma, Inc, Chapel Hill, North Carolina, United States
Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2008-10-20
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 24
- Registration Number
- NCT00775359
- Locations
- 🇺🇸
MDS Pharma Services, Phoenix, Arizona, United States
Bioequivaelnce Study of Doxycycline Monohydrate 100mg Tablets Under Fed Conditions
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2008-10-20
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT00775918
- Locations
- 🇺🇸
aaiPharma, Inc., Chapel Hill, North Carolina, United States
Bioequivalence Study of Clarithromycin 500mg Tablets Under Fasting Conditions.
- First Posted Date
- 2008-10-17
- Last Posted Date
- 2008-11-18
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 33
- Registration Number
- NCT00774644
- Locations
- 🇺🇸
Gateway Medical Research Inc., St.Charles, Missouri, United States
Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting Conditions
- First Posted Date
- 2008-10-17
- Last Posted Date
- 2008-10-17
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT00774189
- Locations
- 🇮🇳
Ranbaxy Research Laboratories, Gurgaon, Haryana, India
Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting Conditions
- First Posted Date
- 2008-10-17
- Last Posted Date
- 2008-10-17
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 24
- Registration Number
- NCT00774696
- Locations
- 🇺🇸
Gateway Medical Research Inc., St.Charles, Missouri, United States